Total Funding
1
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
-13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Partikula develops nanoparticle drug delivery technology for treatment of cancer.
About the Company
Partikula utilizes its proprietary chemical engineering technologies to develop compounds that specifically and directly target mitochondria, from the outer mitochondrial membrane to the mitochondrial matrix and areas in between. By utilizing their technologies they can now access a large number of important and in some cases well-studies targets
that until now have been difficult to target with traditional therapies. Their initial clinical focus is in oncology although they do have programs in earlier stages of development in the areas of neurodegenerative, cardiovascular, and orphan mitochondrial disease.
